跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,252 条关于
“ARV-6723”
全部
10,252
临床试验
9,049
药物
818
机构
23
资讯
362
20小时前
Arvinas doses first patient with oral HPK1 PROTAC degrader ARV-6723 in advanced solid tumors
去年
Bavdegalutamide (ARV-110) Shows Promise as AR Degrader in Preclinical Prostate Cancer Models
9个月前
Arvinas Reports Promising Preclinical Data for ARV-393 and Glofitamab Combination in B-Cell Lymphoma
去年
Arvinas to Present Promising Preclinical Data on PROTAC BCL6 Degrader ARV-393 at AACR 2025
2个月前
Zimbabwe's Black Market ARV Use in Poultry: A Growing Public Health Threat
去年
Arvinas' ARV-102 Shows Promising Brain Penetration and LRRK2 Reduction in First-in-Human Parkinson's Trial
去年
HIV Cure Trial in South Africa Targets Women with Early ARV Intervention
去年
Tenaya Therapeutics Doses First Patient in Phase 1b Trial of TN-401 Gene Therapy for ARVC
去年
Arvinas Advances Vepdegestrant into Phase 3 Trials for Breast Cancer and Updates Pipeline Milestones
7个月前
Arvinas Appoints Randy Teel as CEO Following First Successful PROTAC Pivotal Trial
第 1 页,共 37 页
上一页
下一页